EBMT-EHA CAR-T 2019 | The future landscape of CAR T-cell therapy

Elaine Vickers

In this video, Elaine Vickers, PhD, of Science Communicated Ltd., Manchester, UK, discusses the future of immunotherapy with CAR T-cells. Speaking at the 1st European CAR T-Cell Meeting, held in Paris, France, Dr Vickers mentions the most anticipated upcoming strategies that may improve the performance of CAR T-cell therapy in treating cancer. This meeting was co-organized by the European Society for Blood & Marrow Transplantation (EBMT) and the European Hematology Association (EHA).

Share this video